Swampscott, MA, United States of America

George Adaniva


Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 687(Granted Patents)


Company Filing History:


Years Active: 1992-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by George Adaniva in Infusion Systems

Introduction

George Adaniva is a notable inventor based in Swampscott, MA (US). He has made significant contributions to the field of medical technology, particularly in the development of advanced infusion systems. With a total of 3 patents to his name, Adaniva's work focuses on improving patient care through innovative solutions.

Latest Patents

Adaniva's latest patents include an "Infusion system having plural fluid input ports" and an "Infusion system having plural fluid flow lines." Both patents describe systems designed for administering multiple infusates at individually programmable rates, volumes, and sequences. These systems allow for continuous or time-sequential administration of infusates, with features that automatically detect error conditions and generate alarms in case of conflicts. The systems are operable in various modes, including priming, maintenance, and manual override. They also ensure that all fluids flow through a unitary disposable cassette, minimizing contact with the system and enhancing safety.

Career Highlights

George Adaniva is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to further develop his innovative infusion systems, contributing to advancements in patient treatment and care.

Collaborations

Adaniva has collaborated with notable colleagues such as Paul Epstein and Harry Petschek. These collaborations have fostered a creative environment that encourages the development of cutting-edge medical technologies.

Conclusion

George Adaniva's contributions to infusion systems exemplify the impact of innovation in healthcare. His patents reflect a commitment to enhancing patient safety and treatment efficacy through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…